skip to main content

Our lawyers provide innovative and practical counsel on a wide variety of capital raising and securities law compliance matters. We represent clients ranging from emerging private companies to established public companies. With each, we build long-term relationships, generating efficiencies and helping them realize their business goals.

Vantage Oncology Closes Notes Offering

Paul, Weiss client Vantage Oncology, LLC and and its corporate co-issuer, Vantage Oncology Finance Co., closed a Rule 144A/Regulation S offering of $250 million aggregate principal amount of 9.500% Senior Secured Notes due 2017 and the concurrent amendment and restatement of a $25 million revolving credit facility. The initial purchasers were Jefferies LLC, SunTrust Robinson Humphrey, Inc. and BMO Capital Markets Corp. and affiliates of those entities were the lenders under the revolving credit facility. Based in Manhattan Beach, California, Vantage Oncology provides radiation therapy and related oncology services through 46 treatment centers in 12 states. Paul, Weiss client, Oak Hill Capital Partners, is the majority shareholder of Vantage Oncology.

The Paul, Weiss team included corporate partners Eric Goodison, John Kennedy, Lawrence Wee and counsel Sarah Mudho; employee benefits partner Robert Fleder; tax partner David Sicular and counsel Alyssa Wolpin; and intellectual property counsel Claudine Meredith-Goujon.

June 6, 2013

© 2019 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy